Nathan C. Gianneschi

Nathan C. Gianneschi, Ph.D. is the scientific founder of Grove Biopharma. He received his B.Sc (Hons) at the University of Adelaide, Australia in 1999 and his Ph.D at Northwestern University in 2005. Following a postdoctoral fellowship at The Scripps Research Institute, he began his career at the University of California, San Diego in 2008. In July of 2017, Prof. Gianneschi moved his multidisciplinary research group to Northwestern University where he is currently Jacob & Rosaline Cohn Professor of Chemistry, Materials Science & Engineering, Biomedical Engineering and Pharmacology. The Gianneschi group takes an interdisciplinary approach to research, with interests that include biomedical applications, programmed interactions with biomolecules and cells, and basic research into nanoscale materials design, synthesis and characterization. For this work, he has been awarded the NIH Director’s New Innovator Award, the NIH Director’s Transformative Research Award and the White House’s highest honor for young scientists and engineers with a Presidential Early Career Award for Scientists and Engineers. Prof. Gianneschi was awarded a Dreyfus Foundation Fellowship, is a Kavli Fellow of the National Academy of Sciences, a Fellow of the Royal Society of Chemistry, and is an Alfred P. Sloan Foundation Fellow.